throbber

`

`

`

`
`
`NOTICE AND WARNING
`
`Concerning US. Patent or Trademark Rights
`
`The inclusion in the Pharmacopeizt or in the National Formulary of it monograph on any
`drug in respect to which patent or trademark rights may exist shall nut be deemed. and is
`not intended us. at grant of. or authority to exercise, any right or privilege protected by such
`patent or trademark. All such rights and privileges are vested in the patent or trademark
`owner. and no other person may exercise the same without express permission. ttutherity. or
`iieense secured from such patent or trademark owner.
`
`Concerning Use of USP or NF Text
`Attention is called to the fttct that US? and NF text is fully copyrighted. Authors and
`Others wishing to use portions of the text should request permission to do so from the
`Secretary of the USPC Board of Trustees.
`
`The United States Pharmacopeial Convention. Inc.
`I994
`ta
`I260] Twitthroolt Parkway. Rotkville. MD 20352.
`AN rigklx reserved
`ISSN 0195-7996
`ISBN 0-91359546-4 [cloth]
`0~9l359$-SI-0 (leather)
`
`Printed by Rand McNally.
`
`1 I33 County Street. Taunton. MA 02780-3795
`
`|nnoPharma Exhibit 1113.0003
`
`

`

`
`
`General Notices
`and Requirements
`
`Applying to Standards, Tests,
`Assays, and Other Specifications
`of the United States Pharmacopeia
`
`Guide to GENERAL NOTICES AND REQUIREMENTS
`
`Title .
`
`.
`
`. 2
`
`“Official” and “Official
`Articles” .
`.
`. 2
`
`Nutritional Supplements .
`
`.
`
`. 2
`
`Montic Weights and Chemical
`Formulas .
`.
`. 2
`
`. 3
`.
`Abbreviations .
`Abbreviated Statements in
`Monographs... 3
`
`Significant Figures and
`Tolerances .
`.
`. 3
`
`Equivalence Statements in Titrimetric
`Procedures .. . 3
`Tolerances .. . 3
`Interpretation of Requirements .
`
`. 3
`
`.
`
`General Chapters .
`
`.
`
`. 4
`
`. 4
`
`.
`Pliarmacopeial Forum .
`Pltarmacopeial Previews .
`.
`. 4
`lnjprocess Revision .
`.
`. 4
`Stimuli to the Revision Process .
`Nomenclature .
`.
`. 4
`3‘r‘F’aEi‘!.i {'i§lii§.§‘c;"§i‘§.?鑧?é'£“.".‘.‘4“ 4
`
`.
`
`. 4
`
`Reagent Standards .
`
`.
`
`. 4
`
`USP Reference Standards .
`
`.
`
`. 4
`
`Units of Potency .
`
`.
`
`. 5
`
`Ingredients and Processes .
`Water . ._ 5
`Alcohol .
`.
`. 5
`Alcohol 5
`D"hi'dratcd Alcohoi .
`Denatured Alcohol .
`.
`
`. 5
`.
`. 5
`
`.
`
`. 5
`
`. 6
`.
`Added Substances .
`. 6
`.
`Nutritional Supplements .
`Additional Ingredients .
`.
`. 6
`Inert Headspace Gases .
`. 6
`_
`Colors .
`.
`. 6
`Ointments and Suppositortes .
`
`.
`
`.
`
`. 6
`
`Tests and Assays .
`
`. . 6
`
`.
`
`.
`
`.
`
`. 8
`
`.,
`
`. 8
`
`.
`
`. B
`
`. 6
`.
`Apparatus .
`.
`. 6
`Steam Bath .
`Water Bath . .. 6
`Foreign Substances and Impurities .
`Procedures .
`.
`. 7
`Blank Determination .
`Desiccator .
`.
`. 8
`Dilution .
`.
`. 8
`Drying to Constant Weight .
`Filtration .
`.
`. 8
`. 8
`.
`Identification Tests .
`Ignition to Constant Weight .
`Indicators .
`.
`. 8
`Logaritlirns .
`.
`. B
`Microbial Strains
`Negligible... 3
`Odor... 3
`Pressure Measurements .
`Solutions .
`.
`. 9
`.
`Specific Gravity .
`Temperatures .
`.
`. 9
`Time Limit .
`.
`. 9
`Vacuum .
`.
`. 9
`Water .
`.
`. 9
`Water and Loss on Drying .. . 9
`Test Results, Statistics and
`Standards .
`.
`. 9
`Description .
`.
`. 9
`Solubility .
`.
`. 10
`Prescribing and Dispensing . ..I0
`
`. S
`
`. 9
`
`.
`
`. 9
`
`Preservation, Packaging, Storage,
`and Labeling .
`.
`. 10
`
`4
`. 10
`.
`Containers .
`. I0
`.
`Tamper-resistant Packaging .
`Light-resistant Container .
`.
`. I0
`
`.
`
`. I0
`
`.
`
`Well-closed Container .
`Tight Container .
`.
`. I0
`Hermetic Container . .. ll
`Single-unit Container .
`.
`. ll
`Single-close Container .
`. ll
`.
`Unit-dose Container .
`.
`. ll
`I I
`Multiple-unit Container .
`.
`. ll
`.
`Multiple-dose Container .
`Storage Temperature .. . ll
`Freezer .. . 11
`Cold...ll
`Cool...ll
`Room Temperature .. . ll
`Controlled Room Temperature .
`Warm .
`.
`. 1]
`. ll
`.
`Excessive Heat .
`Protection from Freezing .
`Storage under Nonspecific
`Conditions . .. Ii
`Labeling... I1
`Amount of Ingredient per Dosage
`Unit... 11
`Labeling of Salts of Drugs .
`Labeiing Vitamin-containing
`Products . .. 12
`Labeling Parenteral and Topical
`Preparations . .. [2
`Labeling Electrolytes .
`.
`Labeling Alcohol .
`.
`. [2
`Special Capsules and Tablets
`Expiration Date .
`.
`. 12
`
`.
`
`.
`
`. 11
`
`.
`
`. 12
`
`. 12
`
`. ll
`
`I2
`
`Vegetable and Animal
`Substances .
`.
`. 13
`
`. 13
`.
`Foreign Matter .
`Preservation .
`.
`. 13
`
`Weights and Measures .
`
`.
`
`. 13
`
`Concentrations . .
`
`. 13
`
`. 14
`.
`Percentage Measurements .
`. 14
`Percent weight in weight .
`.
`Percent weight in volume .. . 14
`Percent volume in volume .
`.
`.
`I-3
`
`|nnoPharma Exhibit 1113.0004
`
`

`

`-“in an appropriate period of time dur-
`Inwctllggplngllpresgcripytioq drug may be retained by :1
`its dispensing, the dispenser shall take
`aunt in addition to any other relevant factors.
`into acc 6 0} the drug; the container in which it was
`the until; 1”, the manufacturer and the expiration date
`P§'°kagc.t1;e characteristics of the patient’s container.
`therwmriicle is repackaged for dispensing; the ex-
`it mi-3 image conditions to which the article may be
`13°“: ed. and the expected length of time of the course
`a thcrfli,y_ Unless otherwise required. the dispenser
`of
`on taking into account the foregoing, place on
`$?fabe| of a multiple-unit container at suitable be-
`*nd-use date to limit the patient’s 1.158" of the article.
`gjonlcss otherwise specified in the individual mono-
`ph, such beyond-use date shall be not later than
`53 the expiration date on the manufacturer’s con-
`tainer’ 01- (b) one year from the date the drug 15
`dispensed, whichever is earlier.
`
`VEGETABLE AND rliNll'v‘lAL SUBST.-U'*~'CES
`
`The requirements for vegetable and animal sub-
`stances apply to the articles as they enter commerce;
`however, lots of such substances intended solely _for
`the manufacture or isol'ation_ol' volatile oils, alkaloids.
`glycosides, or other active principles may depart from
`such requirements.
`Statements of the distinctive microscopic structural
`elements in powdered substances of animal or vege-
`table origin may be included in the individual mono-
`graph as a means of determining identity, quality, or
`purity.
`
`Foreign Matter—Vegetable and animal substances
`are to be free from pathogenic organisms (see Mi‘-
`crobioiogical Attributes of Nonsterile Pharmaceu-
`tical Products (I l
`1 1)). and are to be as free as rea-
`sonably practicable from microorganisms, insects, and
`other animal contamination,
`including animal ex-
`creta. They shall show no abnormal discoloration,
`a_bnor_mal odor, sliminess, or other evidence of dete-
`rioration.
`The amount of foreign inorganic matter in vege-
`table or animal substances, estimated as Aci'd—i’n.rol‘-
`uble ash, shall not exceed 2 percent of the weight of
`the substance. unless otherwise specified in the in-
`dividual monograph.
`Bclore vegetable substances are ground or pow-
`?:;:§é:il;)neS, dust. lumps of soil, and other foreign
`matter are to be removed by mechanical or
`other suitable means.
`Edit‘; étirlraisiiiaelrce it
`is seldompossible to obtain vege-
`d
`.
`M
`_
`ces that are without some adherent or
`3 mixed. innocuous, foreign matter, which usually is
`agfiedggggfintfal.
`'No poisonous, diiggerous, 01;‘ other-
`_ 5 oreign matter or resi
`ties may e pres-
`;=1nt. Foreign matter includes any part of the plant
`‘“ Speciiled as constituting the substance.
`P|'eservation——VegetabIe or animal substances may
`bl’-‘ protected from insect infestation or microbiolog-
`
`Genern! Notices
`
`13
`
`ical contamination by means of suitable agents or
`processes that leave no harmful residues.
`
`wcioirrs AND MEASURES
`
`The international System of Units (Si) is used in
`this Pharrnacopeia. The S1 metric and other units,
`and the symbols commonly employed, are as follows.
`Ci = curie
`Eq = grant-equivalent
`mCi == millicuric
`weight (equivalent)
`uCi = rnicrocurie
`mE = milliequivalent
`nCi = nanociiric
`mo = gram-molecular
`vv
`Mmd = mcsarnd
`Da = daltcinlgh mo-
`lecular mass)
`in = mctcr
`mmol = niillimole
`din =- dcciincter
`Osmol = osrnole
`em = centimeter
`mDsmol = rnilliosrnolc
`mm = millimeter
`Hz = hertz
`um = micrometer
`lcl-iz = liiiohertz
`(0.001 mm)
`Ml-lz = megahertz
`Mo =- nanometer‘
`MeV = million electron
`kg =' kilogram
`volts
`= gram "
`keV = kilo-electron volt
`mg -== milligram
`rnV = millivolt
`rig: meg == microgrami
`psi = pounds per square
`rig = nanogram
`inch
`pg ==- picogriim
`Pa = pascal
`dL E deciliter
`kl"-‘a = kilopascal
`L = liter
`g = gravity (in
`mL = milliliter: i
`centrifugatiori)
`uL = microliter
`
`' Formerly the symbol min (for millimicronj was used.
`“ The grain is the unit of mass that is used to measure quan-
`tities of rniiicrials. Weight. which is a measure of the gravita-
`tional force acting on the mass of a material, is proportional to.
`and may differ slightly from. its mass due to the effects of factors
`such as gravity. temperature. latitude, and altitude. The differ-
`ence between mass and weight is considered to be insignificant
`for compendial assa '5 and tests, and the term “wcight" is used
`throughout USP an NF.
`'l“Formcrly the abbreviation meg was used in the Pharmaco-
`pcinl monographs: however. the symbol pig now is more widely
`accepted and thus is used in this Pharmaco eia. The term
`"gamma," symbolized by 7, is frequently used or n-iicrogram in
`biochemical literature.
`l"~l0'rt3—Thc abbreviation meg is still commonly employed to
`denote microgramis) in labeling and in prescription writing.
`Tiiercforc. for purposes of labeling, “mcg" may be used to denote
`micrograms).
`It One milliliter (mL) is used herein as the equivalent of 1 cubic
`centimeter (cc).
`
`The International System of Units (S1) is also used
`in all radiopharmaceutical monographs. The symbols
`commonly employed are as follows.
`Bq = bccqucrcl
`GBq = gigabccquerel
`kBq = ltilobccquerel
`Gy = gray
`MBq = megabec-
`trtGy = milligray
`qucrel
`
`CONCENTRATIONS
`
`Molal, molar. and normal solution concentrations
`are indicated throu bout this Pharinacopeia for most
`chemical assay ant? test procedures (see also Volu-
`metric Solimoris in the section, Reagents, Indicators,
`and Soliiiions). Molality is designated by the symbol
`in preceded by a number that is the number of moles
`of the designated solute contained in one kilogram of
`
`l l 3
`
`|nnoPharma Exhibit 1113.0005
`
`
`
`
`
`!—!—u-n-—--iii--11117:!‘-I.-I’-'..'-I‘-ct:D.-'-'ul:‘l'?-ii
`
`

`

`14
`
`General’ Notices
`
`USP 23
`
`
`
`the designated solvent. Molarity is designated by the
`symbol M preceded by a number that is the number
`of moles of the designated solute contained in an
`amount of the designated solvent that is sufficient to
`prepare one liter of solution. Normality is designated
`by the symbol N preceded by a number that is the
`number of equivalents of the designated solute con-
`tained in an amount of the designated solvent that is
`sufficient to prepare one liter of solution.
`
`Percentage Measurements—Percentage concentra—
`tions are expressed as follows:
`Percent weight
`in wet'g}zt~(w/w) expresses the
`number of g of a constituent in 100 g of solution or
`mixture.
`
`in voIume—(w/v) expresses the
`Percent weight
`number of g of a constituent in 100 ml. of solution.
`
`and is used regardless of whether water or another
`liquid is the solvent.
`Percent volume in vo!ume—(v/vi) expresses the,
`number of mL of a constituent in 100 mL of solution,
`The term percent used without qualification means_
`for mixtures of solids and semisolids, percent ‘Weight
`in weight; for solutions or suspensions of solids in
`liquids, percent weight
`in volume; for solutions of
`liquids in liquids, percent volume in volume; and for
`solutions of gases in liquids, percent weight in volume,
`For example, a 1 percent solution is prepared by dis.
`solving 1 g of a solid or semisolid, or 1 mL of a liquid,
`in sufficient solvent to make I00 ml. of the solution.
`In the dispensing of prescription medications. slight
`changes in volume owing to variations in room tem-
`peratures may be disregarded.
`
`>i>>->-:I~:h-
`
`
`
`4t——m:%:jé: pl-I—p«q¢:u
`
`|nnoPharma Exhibit 1113.0006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket